UNSPSC 51111760: Pixantrone

This classification denotes an intercalating agent with the molecular formula C17H19N5O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F5SXN2KNMR, chemically known as 6,9-bis((2-aminoethyl)amino)benzo(g)isoquinoline-5,10-dione but generally known as pixantrone, which bears US NIH Compound Identifier 134019. European Medicines Agency schedules Pixantrone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21304.

UNSPSC 51111760 Pixantrone, a Commodity code, identifies pharmaceutical active pharmaceutical ingredients and finished drugs sourced through state and local procurement channels, though the recent opportunities block shows minimal activity directly tagged to this specific code. The opportunities that do surface under this taxonomy classification reveal a fragmented procurement pattern: Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract to Chartwell Rx LLC through the MMCAP Infuse consortium for antibiotic tablets (Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg), while Seminole County, Florida pursued a separate competitive bid for Naloxone and drug deactivation systems with annual quantities of 1,900 units and 800 units respectively. Neither opportunity directly names Pixantrone as a line item, suggesting the code's assignment may reflect broader pharmaceutical procurement categories rather than specific active-ingredient targeting.

State and local health departments and county public health agencies drive the visible demand in this space, with opportunities concentrated in Florida and Illinois based on recent postings. The Illinois PREPD contract represents a closed award (IFB process, awarded August 28, 2026) with a 12-month initial term and two renewal options, while the Seminole County opportunity (IFB60459723LAS, originally posted June 30, 2026 with a July 26, 2023 response date—suggesting a data inconsistency in the source record) specified quarterly delivery cycles and included FEMA compliance requirements. Both procurements emphasize fixed-fee pricing, vendor responsibility for delivery costs, and standard workplace certifications (drug-free workplace, E-Verify). No set-asides or enterprise preferences are documented in these records, and no business development momentum is evident under this specific commodity code; opportunities appear episodic rather than recurring.